See also this year's filing and all EDGAR filings for this company.
PDF Report 0001366541_2014_Q_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001366541, Q Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 221,530 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 27,999 |
| 3 | remainder_Assets | 7,513 |
| 4 | LiabilitiesCurrent | 3,299,107 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,800 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,384,712 |
| 9 | ResearchAndDevelopmentExpense | 1,827,533 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 26,175 |
| 12 | remainder_NetIncome | -198,222 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 257,042 |
| 1 | Liabilities | 3,299,107 |
| 2 | Expenses | 3,217,045 |
| 3 | Revenues | 26,175 |
| 4 | StockholdersEquity | -3,042,065 |
| 5 | NetIncome | -3,389,092 |
| 6 | ComprehensiveNetIncome | -3,389,092 |
| 7 | BaseVar | 3,498,796 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.64 |
| 9 | EconomicCapitalRatio | 0.111 |
Edgar->Model Mapping
Feature Distribution
Change over Time
